HYPERA S A/S (OTCMKTS:HYPMY) and Estee Lauder Companies (NYSE:EL) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Insider and Institutional Ownership

0.2% of HYPERA S A/S shares are owned by institutional investors. Comparatively, 56.0% of Estee Lauder Companies shares are owned by institutional investors. 16.1% of Estee Lauder Companies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Volatility and Risk

HYPERA S A/S has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500. Comparatively, Estee Lauder Companies has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500.

Dividends

HYPERA S A/S pays an annual dividend of $0.26 per share and has a dividend yield of 3.2%. Estee Lauder Companies pays an annual dividend of $1.72 per share and has a dividend yield of 1.2%. Estee Lauder Companies pays out 38.1% of its earnings in the form of a dividend. Estee Lauder Companies has raised its dividend for 4 consecutive years.

Profitability

This table compares HYPERA S A/S and Estee Lauder Companies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
HYPERA S A/S 31.62% 13.69% 10.97%
Estee Lauder Companies 8.48% 38.29% 14.00%

Analyst Recommendations

This is a summary of recent ratings and recommmendations for HYPERA S A/S and Estee Lauder Companies, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HYPERA S A/S 0 0 0 0 N/A
Estee Lauder Companies 0 5 18 0 2.78

Estee Lauder Companies has a consensus target price of $146.24, suggesting a potential upside of 3.94%. Given Estee Lauder Companies’ higher possible upside, analysts plainly believe Estee Lauder Companies is more favorable than HYPERA S A/S.

Valuation & Earnings

This table compares HYPERA S A/S and Estee Lauder Companies’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
HYPERA S A/S $538.51 million 9.56 $302.21 million N/A N/A
Estee Lauder Companies $13.68 billion 3.73 $1.11 billion $4.51 31.20

Estee Lauder Companies has higher revenue and earnings than HYPERA S A/S.

Summary

Estee Lauder Companies beats HYPERA S A/S on 10 of the 15 factors compared between the two stocks.

HYPERA S A/S Company Profile

Hypera S.A. operates as a pharmaceutical company in Brazil. The company offers prescription medications under the Farmasa, Neo Química, and Luper brands; and over-the-counter medications comprising laxative, antacid, antispasmodic, topical antiseptic, topical, nasal decongestant, and other drugs under Gelol, Anapyon, Biotônico Fontoura, Epocler, Merthiolate, Tamarine, and Rinosoro brands. It also provides similars and generics under the Neo Química brand; dermocosmetics under the Lanidrant, Agecare, Dersab, Epidac, Epidrat, Episol, Hidramamy, Creme rejuvenecedor, Blancy, and Pielus brands; and food supplements and sweeteners. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. The company was founded in 2001 and is headquartered in São Paulo, Brazil.

Estee Lauder Companies Company Profile

The Estée Lauder Companies Inc. manufactures and markets skin care, makeup, fragrance, and hair care products. The company offers a range of skin care products, such as moisturizers, serums, cleansers, toners, body care products, exfoliators, acne care products, facial masks, cleansing devices, and sun care products; and makeup products, including lipsticks, lip glosses, mascaras, foundations, eyeshadows, nail polishes, and powders, as well as related items, including compacts, brushes, and other makeup tools. It also provides fragrance products in various forms comprising eau de parfum sprays and colognes, lotions, powders, creams, candles, and soaps; and hair care products consisting of shampoos, conditioners, styling products, treatment, finishing sprays, and hair color products, as well as sells ancillary products and services. The company offers its products under the brand names of Estée Lauder, Aramis, Clinique, Prescriptives, Lab Series, Origins, M·A·C, Bobbi Brown, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin, Ojon, Smashbox, RODIN olio lusso, FLIRT!, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, By Kilian, BECCA, and Too Faced. In addition, it operates as a licensee for fragrances and/or cosmetics sold under the Tommy Hilfiger, Donna Karan New York, DKNY, Kiton, Michael Kors, Tom Ford, Dr. Andrew Weil, Ermenegildo Zegna, AERIN, and Tory Burch brand names. The company sells its products through department stores, specialty multi-brand retailers, upscale perfumeries, pharmacies, and salons and spas; freestanding stores; e-commerce Websites; stores in airports and on cruise ships; in-flight and duty-free shops; and self-select outlets. It has operations in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The Estée Lauder Companies Inc. was founded in 1946 and is based in New York, New York.

Receive News & Ratings for HYPERA S A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HYPERA S A/S and related companies with MarketBeat.com's FREE daily email newsletter.